Latest News and Updates

BLFA Funds 3 New Projects to Reduce Cancer Treatment Abandonment

Children in Africa die from cancer because their families face multiple social and economic barriers to keeping them in cancer treatment. This September for Childhood Cancer Awareness Month BLFA is committing $30,000 to three innovative new projects that aim to reduce these barriers and increase a child’s chance for survival.

Read More »

You Tell Us: How Should We Go Global in 2022?

BLFA’s goal is to increase the survival rate of children with cancer in underserved countries. There are astounding global inequities in all aspects of curing these children. Our vision is to help more children in 2022. Read on and contact us with your thoughts. We look forward to talking to you!

Read More »

Quest Equipment Donation Helps African Labs

More accurate and faster diagnoses increases a child’s chance for survival. In collaboration with board member Dr. Steve Kussick, Quest recently donated equipment to help expand the diagnostic capabilities of our lab partners in Africa.

Read More »

Research Completed by BLFA Board Members, Program Partners, and Collaborators:

“Survival of children with endemic Burkitt’s lymphoma in a prospective clinical care project in Uganda”
[Pediatric Blood and Cancer, September 2019, Volume 66, Issue9]
https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.27813

“Cost Effectiveness of Treating Burkitt’s Lymphoma in Uganda”
[Cancer, Volume 125, Issue 11, June 1, 2019]
https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.32006 

“Presentation and Outcomes of Childhood Cancer Patients at Uganda Cancer Institute”
[Global Pediatric Health, May 2019]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537233/

“Prospective study of Burkitt’s lymphoma treatment in adolescents and adults in Malawi”
[Blood Journal 2019 Feb 26; 3(4): 612–620]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391663/

“Pediatric Cancer in Northern Tanzania: Evaluation of Diagnosis, Treatment, and Outcomes”
[Journal of Global Oncology, v4, 2018]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180837/

“Accuracy of Burkitt’s Lymphoma Diagnosis in Constrained Pathology Settings: Importance to Epidemiology”
[Archives of Pathology and Laboratory Medicine, Volume 135, Issue 4, April 2011]
https://www.archivesofpathology.org/doi/full/10.1043/2009-0443-EP.1

“Burkitt’s lymphoma in Africa, a review of the epidemiology and etiology”
[African Health Sciences, 2007 Sep; 7(3): 166–175]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2269718/